CETROTIDE

This brand name is authorized in Austria, Australia, Brazil, Cyprus, Ecuador, Estonia, Spain, Finland, France, Hong Kong, Croatia, Ireland, Israel, Japan, Lithuania, Mexico, Nigeria, Netherlands, New Zealand, Poland, Romania, Singapore, Tunisia, Turkey, United Kingdom

Active ingredients

The drug CETROTIDE contains one active pharmaceutical ingredient (API):

1 Cetrorelix
UNII W9Y8L7GP4C - CETRORELIX ACETATE

Cetrorelix is a synthetic decapeptide with gonadotropin-releasing hormone (GnRH) antagonistic activity. GnRH induces the production and release of luteinizing hormone (LH) and follicle stimulating hormone (FSH) from the gonadotrophic cells of the anterior pituitary. Due to a positive estradiol (E2) feedback at midcycle, GnRH liberation is enhanced resulting in an LH-surge. This LH-surge induces the ovulation of the dominant follicle, resumption of oocyte meiosis and subsequently luteinization as indicated by rising progesterone levels. Cetrorelix competes with natural GnRH for binding to membrane receptors on pituitary cells and thus controls the release of LH and FSH in a dose-dependent manner. Cetrorelix binds to the gonadotropin releasing hormone receptor and acts as a potent inhibitor of gonadotropin secretion. It competes with natural GnRH for binding to membrane receptors on pituitary cells and thus controls the release of LH and FSH in a dose-dependent manner. Cetrotide (cetrorelix acetate for injection) is indicated for the inhibition of premature LH surges in women undergoing controlled ovarian stimulation.

Read about Cetrorelix

Medication package inserts

Below package inserts are available for further reading:

Title Information Source Document Type  
CETROTIDE Powder and solvent for solution for injection European Medicines Agency (EU) MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code Group title Classification
H01CC02 Cetrorelix H Systemic hormonal preparations, excl. Sex hormones and insulins → H01 Pituitary and hypothalamic hormones and analogues → H01C Hypothalamic hormones → H01CC Anti-gonadotropin-releasing hormones
Discover more medicines within H01CC02

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
Country: AU Pharmaceutical Benefits Scheme Identifier(s): 9599F
Country: BR Câmara de Regulação do Mercado de Medicamentos Identifier(s): 525421701150311
Country: EC Agencia Nacional de Regulación, Control y Vigilancia Sanitaria Identifier(s): 29034-09-09
Country: EE Ravimiamet Identifier(s): 1043356, 1043367, 1064696
Country: ES Centro de información online de medicamentos de la AEMPS Identifier(s): 99100001, 99100002
Country: FI Lääkealan turvallisuus- ja kehittämiskeskus Identifier(s): 005766
Country: FR Base de données publique des médicaments Identifier(s): 60650426
Country: GB Medicines & Healthcare Products Regulatory Agency Identifier(s): 41575
Country: HK Department of Health Drug Office Identifier(s): 46953
Country: IE Health Products Regulatory Authority Identifier(s): 88452, 88819
Country: IL מִשְׂרַד הַבְּרִיאוּת Identifier(s): 4054
Country: JP 医薬品医療機器総合機構 Identifier(s): 2499421D1023
Country: LT Valstybinė vaistų kontrolės tarnyba Identifier(s): 1006177, 1006178
Country: MX Comisión Federal para la Protección contra Riesgos Sanitarios Identifier(s): 519M2001
Country: NG Registered Drug Product Database Identifier(s): B4-8486
Country: NL Z-Index G-Standaard Identifier(s): 14639580
Country: NL Z-Index G-Standaard, PRK Identifier(s): 52795
Country: NZ Medicines and Medical Devices Safety Authority Identifier(s): 8400
Country: PL Rejestru Produktów Leczniczych Identifier(s): 100094481
Country: RO Agenția Națională a Medicamentului și a Dispozitivelor Medicale Identifier(s): W65132001, W65132002
Country: SG Health Sciences Authority Identifier(s): 11345P
Country: TN Direction de la Pharmacie et du Médicament Identifier(s): 22073051, 4703021, 4703022
Country: TR İlaç ve Tıbbi Cihaz Kurumu Identifier(s): 8699777790225, 8699777790232

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.